Coronavirus Disease (COVID-19)-Related Disseminated Leukoencephalopathy: A Retrospective Study of Findings on Brain MRI.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 32903058.
- Also identified by DOI 10.2214/AJR.20.24364 and PMC identifier 9985006.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Among 2820 inpatients with coronavirus disease (COVID-19), 59 (2.1%) underwent brain MRI. Of them, six (10.2%) had MRI findings suspicious for COVID-19-related disseminated leukoencephalopathy (CRDL), which is characterized by extensive confluent or multifocal white matter lesions (with characteristics and locations atypical for other causes), microhemorrhages, diffusion restriction, and enhancement. CRDL is an uncommon but important differential consideration in patients with neurologic manifestations of COVID-19.
Medical subject headings
- Brain
- COVID-19
- Leukoencephalopathies
- Magnetic Resonance Imaging
- Pandemics
- SARS-CoV-2